Diabetes and aging: a different phenotypic commitment of circulating and resident stem cells?
- PDF / 120,775 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 86 Downloads / 155 Views
LETTER TO THE EDITOR
Diabetes and aging: a different phenotypic commitment of circulating and resident stem cells? Amedeo Ferlosio • Augusto Orlandi
Received: 12 September 2012 / Accepted: 13 September 2012 / Published online: 5 October 2012 Ó Springer-Verlag Italia 2012
Atherosclerosis is a vascular disease largely attributed to chronic vascular injury, and its clinical manifestations appear more frequently in aged subjects. Accumulation of vascular smooth muscle cells in the tunica intima plays a major role in the pathogenesis of atherosclerosis. Arterial smooth muscle cells are heterogeneous even in the normal vessel wall and display more marked different phenotypes in pathological conditions. Smooth muscle cells in atherosclerotic plaques display a de-differentiated or ‘‘synthetic’’ phenotype compared to a ‘‘contractile’’ phenotype in the normal media. Aorta stiffens with age and other cardiovascular risk factors. In particular, diabetes-induced activation of the renin–angiotensin system increases the expression of angiotensin II, further increasing aortic calcification and stiffness. Thus, alterations of aortic and carotid walls in patients with diabetes were traditionally considered a sort of ‘‘accelerated aging.’’ In the last years, the contribution of stem cells to atherosclerosis has been highlighted. Bone marrow and peripheral blood-derived endothelial and vascular smooth muscle cell resident progenitors both contribute to vascular remodeling during atherogenetic process and aging [1]. Both circulating and resident progenitor cells have been evocated to contribute to the response of the adult arterial wall to damage. Chronic treatment with bone marrow-derived progenitor cells from young non-atherosclerotic ApoE-/- mice prevents atherosclerosis progression in ApoE-/- recipients despite persistent hypercholesterolemia, whereas bone
Communicated by Massimo Federici. A. Ferlosio A. Orlandi (&) Department of Biomedicine and Prevention, University of Rome, ‘‘Tor Vergata’’ Via Montpellier 1, 00133 Rome, Italy e-mail: [email protected]
marrow-derived progenitor cells from older ApoE-/- mice with atherosclerosis were much less effective [2]. These findings suggest that the progressive bone marrow-derived progenitor cells deficit may contribute to the development of atherosclerosis. Nevertheless, atherosclerotic lesions are characterized from the increase of stem cell markerexpressing cells, and macroscopically normal aortas from human and rat aged donors show an increased number of VEGFR-1? and c-kit? cells in the thickened intima [3]. Also, diabetes alters the function of circulating progenitor cells. Depletion of bone marrow-derived angiogenic cell populations may further promote atherogenesis and aortic calcification in patients with diabetes mellitus [4]. In multivariable analyses, the increase in colony-forming units from endothelial progenitor cells was associated with the decrease in coronary artery and abdominal aortic calcification [5]. These changes were not associated with changes in CD34? expres
Data Loading...
